Half of U.S. marijuana consumers say they expect to consume more cannabis under the Trump administration than they have before, according to a new poll. After a tumultuous first three months of President Donald Trump’s second term— with heightened economic anxieties and major restructuring of the federal government—the polling... Read more

The Drug Enforcement Administration (DEA) has notified an agency judge that the marijuana rescheduling process is still on hold—with no future actions currently scheduled as the matter sits before the acting administrator, who has called cannabis a “gateway drug” and linked its use to psychosis. It’s been almost three... Read more

Senators in Hawaii on Wednesday gave approval to a medical marijuana bill that would, among other changes, allow healthcare providers to recommend cannabis to treat any condition they believe it would benefit. The full Senate chamber voted 24–1 to approve HB 302, from Rep. Gregg Takayama (D). As introduced, the... Read more

Without proactive advocacy for marijuana rescheduling from President Donald Trump personally, the process could stall indefinitely, former officials with the Drug Enforcement Administration (DEA) and U.S. Department of Health and Human Services (HHS) say. What’s more, rescheduling proceedings that are currently paused could be suspended altogether if the new... Read more

At a time when agencies across the federal government are seeing massive spending and workforce cuts under the Trump administration, the Drug Enforcement Administration (DEA) is actively ramping up recruitment—urging people to join them on the frontlines of the “war on drugs,” even if they currently work as a... Read more

Governors in Colorado and Virginia have taken action on bills that would allow the prescription of a synthetic form of psilocybin as soon as the federal government authorizes its use. Legislatures in both states passed the bills last month. In Colorado, Gov. Jared Polis (D) signed HB25-1063 into law.... Read more